Company Filing History:

9 out of 2,405

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 2006-2017

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9643983 - Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives (2017-05-09),

2. 9139586 - Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives (2015-09-22),

3. 8697687 - Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives (2014-04-15),

4. 8318935 - Organic compounds 75074 (2012-11-27),

5. 8203004 - Tetrahydroindole derivatives for treatment of alzheimer's disease (2012-06-19),

6. 8039472 - Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel (2011-10-18),

7. 7598386 - Sulphones which modulate the action of gamma-secretase (2009-10-06),

8. 7595344 - Sulphones which modulate the action of gamma secretase (2009-09-29),

9. 7411004 - Sulphones which modulate the action of gamma secretase (2008-08-12),

10. 7410964 - Cyclohexyl sulphones as gamma-secretase inhibitors (2008-08-12),

11. 7304094 - Cyclohexyl sulphones (2007-12-04),

12. 7276637 - Synthesis of cyclohexanone derivatives (2007-10-02),

13. 7101895 - Cyclohexyl sulphone derivatives as gamma-secretase inhibitors (2006-09-05),

14. 6984663 - Cyclohexyl sulphones (2006-01-10),

Title: The Inventor Extraordinaire: Paul Joseph Oakley

Introduction: Paul Joseph Oakley is a prolific inventor hailing from South Benfleet, Great Britain. With an impressive portfolio of 14 patents under his belt, he has made significant contributions to the field of medicine and pharmaceuticals.

Latest Patents: Among his latest patents is the groundbreaking work on "Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives." This revolutionary compound has shown great promise in treating diseases that respond to the blockade of the epithelial sodium channel. The pharmaceutical compositions containing these compounds, as well as the processes for their preparation, have been detailed in his patents.

Career Highlights: Oakley has lent his expertise to renowned companies such as Merck Sharp & Dohme Corporation and Novartis AG. His innovative spirit and dedication to scientific advancements have propelled him to the forefront of the pharmaceutical industry.

Collaborations: Throughout his career, Oakley has had the privilege of collaborating with esteemed professionals in the field. Notable coworkers include Martin Richard Teall and Timothy Harrison, who have worked alongside Oakley in bringing cutting-edge inventions to life.

Conclusion: Paul Joseph Oakley stands as a testament to the power of innovation and dedication in the world of patents and inventions. His relentless pursuit of scientific excellence has left an indelible mark on the industry, and his contributions continue to shape the future of medicine and pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.